A New Approach to Chronic Disease Control
At MedsEngine, we are revolutionizing care management for patients with hypertension, high cholesterol, type 2 diabetes, and heart failure. From achieving nation-leading control rates, higher HEDIS scores, lower cost of care and more satisfied patients, our cutting-edge solutions are making a notable difference in lives across the country.
MedsEngine utilizes cutting-edge technology: cloud-based clinical modules integrate seamlessly into existing electronic health record (EHR) systems and provide recommendations tailored to the unique profile of each patient.
Once the data is reviewed, MedsEngine processes the data and generates real-time, focused medication recommendations and a patient summary.
Chronic Disease Modules
Hypertension
MedsEngine hypertension utilizes hemodynamic data and other personal clinical factors to generate personalized treatment recommendations. Practices employing MedsEngine hypertension achieved 85-92% blood pressure control, double the national average. This control was reached in an average of 1.4 visits. The economic impact of this control can be significant, as evidenced by a validated study showing savings of $204 per member per month with 79% control.1
Cholesterol Management
MedsEngine cholesterol applies the 2018 ACC/AHA guideline at the point of care by retrieving 77 cardiovascular risk factors from the patient’s EHR. It then identifies the patient’s specific LDL goal and recommends appropriate therapeutic intervention.
Type 2 Diabetes
MedsEngine diabetes retrieves 38 pertinent clinical factors from the EHR to calculate a personalized A1c goal and generate optimal medication recommendations. A study revealed that a 1% reduction in HbA1c was associated with an annual savings of $736 per patient for diabetes related healthcare costs.2 MedsEngine diabetes is predicted to achieve even greater HbA1c reductions, resulting in similar if not greater savings.
Heart Failure
We are working to update the HFrEF module to the latest AHA/ACC/HFSA guideline for the management of heart failure.
1 https://www.ama-assn.org/delivering-care/hypertension/controlling-chronic-disease-corrals-costs-and-improves-outcomes
2 Maureen J. Lage & Kristina S. Boye (2020) The relationship between HbA1c reduction and healthcare costs among patients with type 2 diabetes: evidence from a U.S. claims database, Current Medical Research and Opinion, 36:9, 1441-1447, DOI: 10.1080/03007995.2020.1787971
